12 May 2023FeaturesJurisdiction reportsNaomi Pearce, Eliza Jane Saunders and Chris Vindurampulle
Australia: Beware the shifting sands of term extensions
There is no limit to the number of PTEs a pharmaceutical patentee can obtain in Australia. It increasingly common for there to be five to ten (or more) patents extended per medicine.
Under the Patents Act 1990 (the Act), the only relevant subject matter limitation is that the patent must disclose and claim:
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk
21 June 2022 Australia’s IP office, IP Australia, and the European Patent Office (EPO) have agreed to continue the patent prosecution highway (PPH) programme, following a successful pilot phase.
10 August 2021 Allowing an AI as an inventor could benefit the country’s pharma and drug discovery industries, say Richard Hamer, Lauren John and Alexandra Moloney of Allens.
7 May 2024 Microsoft-owned Activision Blizzard ordered to pay damages to tech incubator | Activision infringed patents related to tech used in its blockbuster games World of Warcraft and Call of Duty, jury concludes.